Third Rock Ventures IV L.P. 13D/13G Filings for Tango Therapeutics, Inc. (TNGX)

Third Rock Ventures IV L.P. 13D and 13G filings for Tango Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-09-04
8:45 pm
Sale		 2024-08-30 13D Tango Therapeutics, Inc.
TNGX		 Third Rock Ventures IV L.P. 17,001,475
15.900%		 -2,362,500decrease
(-12.20%)		 Filing
2021-08-19
4:35 pm
Purchase		 2021-08-10 13D Tango Therapeutics, Inc.
TNGX		 Third Rock Ventures IV L.P. 19,363,975
22.100%		 19,363,975increase
(New Position)		 Filing